BLACKROCK HEALTH SCIENCES TR's ticker is BME and the CUSIP is 09250W107. A total of 71 filers reported holding BLACKROCK HEALTH SCIENCES TR in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,281 | -2.1% | 364 | +1.7% | 0.00% | – |
| Q2 2023 | $14,590 | -1.4% | 358 | +1.4% | 0.00% | – |
| Q1 2023 | $14,794 | -3.0% | 353 | +1.1% | 0.00% | -100.0% |
| Q4 2022 | $15,247 | -70.7% | 349 | -74.2% | 0.00% | -50.0% |
| Q3 2022 | $52,000 | +62.5% | 1,352 | +78.1% | 0.00% | +100.0% |
| Q2 2022 | $32,000 | -5.9% | 759 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $34,000 | -8.1% | 759 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $37,000 | +2.8% | 759 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $36,000 | -2.7% | 759 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $37,000 | +5.7% | 759 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $35,000 | -2.8% | 759 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $36,000 | +9.1% | 759 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $33,000 | +10.0% | 759 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $30,000 | +66.7% | 759 | +46.5% | 0.00% | +100.0% |
| Q1 2020 | $18,000 | -18.2% | 518 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $22,000 | +46.7% | 518 | +34.5% | 0.00% | +100.0% |
| Q3 2019 | $15,000 | – | 385 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nova R Wealth, Inc. | 410,736 | $16,692,294 | 11.18% |
| Alterity Financial Group, LLC | 12,484 | $507,330 | 0.73% |
| Cornerstone Advisory, LLC | 88,503 | $3,596,759 | 0.63% |
| Owen LaRue, LLC | 13,117 | $528,337 | 0.56% |
| Semus Wealth Partners LLC | 13,170 | $535,229 | 0.49% |
| PRIMORIS WEALTH ADVISORS, LLC | 7,984 | $324,489 | 0.36% |
| CORRADO ADVISORS, LLC | 9,285 | $377,343 | 0.26% |
| Elequin Capital, LP | 9,231 | $375,148 | 0.19% |
| Founders Financial Alliance, LLC | 10,617 | $431,489 | 0.17% |
| Diversified, LLC | 12,412 | $504,432 | 0.13% |